Vaseem Palejwala
Chief Tech/Sci/R&D Officer chez TIZIANA LIFE SCIENCES LTD
Profil
Vaseem A.
Palejwala is a professional with a doctorate degree from the University of Baroda and an undergraduate degree from the University of Mumbai.
He is currently a Senior Director-Clinical Operations at Tiziana Life Sciences Ltd.
He previously worked as a Director-Discovery & Preclinical Research at Synergy Pharmaceuticals LLC, Actavia Life Sciences, Inc., and Tiziana Life Sciences Ltd.
(United Kingdom).
Prior to that, he was a Manager at Sanofi-Synthelabo, Inc. from 2001 to 2012.
Postes actifs de Vaseem Palejwala
| Sociétés | Poste | Début |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Anciens postes connus de Vaseem Palejwala
| Sociétés | Poste | Fin |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Corporate Officer/Principal | 01/01/2019 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2017 |
| Sanofi-Synthelabo, Inc. | Corporate Officer/Principal | 01/01/2012 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Formation de Vaseem Palejwala
| University of Mumbai | Undergraduate Degree |
| University of Baroda | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Sanofi-Synthelabo, Inc. | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
